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Objective: to evaluate whether perioperative haemodynamic optimisation influences outcome from infrarenal abdominal
aortic aneurysm repair.
Methods: a consecutive series of 100 eligible patients were randomised to either haemodynamic optimisation through
the use of a pulmonary artery catheter (CI4 3.0 l/min/sqm, PWP4 10 and 518 mmHg, SVR 51450 dyne/sec/cmÿ5,
DO24 600 ml/min/sqm) or conventional treatment.
Results: there were no differences in terms of in-hospital mortality, cardiovascular morbidity, postoperative renal failure or
duration of hospital stay between the groups.
Conclusions: in this study perioperative haemodynamic optimisation was not beneficial.
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It has been suggested that perioperative haemody-
namic optimisation through pulmonary artery cath-
eter (PAC) monitoring can improve outcome from
aortic surgery.1±8
However, to our knowledge, only one prospective,
randomised study has been performed which showed
no benefit.9 However, the study included patients
with aneurysmal and aorto-iliac occlusive disease.10
Moreover, PAC was used mainly as monitoring device
and not to achieve haemodynamic optimisation.
The lack of evidence and the limited ICU resources
mean we must identify which patients if any really
benefit from intensive perioperative treatment.11,12
We decided therefore to conduct a prospective, ran-
domised pilot study with a limited number of subjects
without clinical and echocardiographic evidence of* Please address all correspondence to: M. Bonazzi, Department of
Anesthesia and Intensive Care Unit, Bassini Hospital ± via M. Gorki,
50 ± 20092 Cinisello Balsamo ± Milano, Italy Tel.: 00390261765271;
Fax: 00390266987579; E-mail: fgentile@iol.it
1078±5884/02/050445  07 $35.00/0 # 2002 Elsevier Science Ltd. AllCAD, in order to assess the rate of major post-
operative cardiac complications after abdominal
aneurysmectomy in relation with the perioperative
strategy outlined above. The results could help in
evaluating the opportunity to conduct a larger, con-
trolled study.
Materials and Methods
Between 1st April 1996 and 30th March 2000, male
patients scheduled for elective infrarenal abdominal
aortic aneurysm (AAA) repair were assessed for car-
diac risk (Fig. 1). Patients were enrolled if they were
aged less than 75 years, asymptomatic for angina and
arrhythmias, without significative alterations of ven-
tricular repolarization at resting ecg, without evidence
of left ventricular wall motion abnormalities at pre-
operative transthoracic echocardiography at rest and
with an ejection fraction  50%. Other preoperative
risk factors analysed included smoking history, hyper-
tension, diabetes mellitus, chronic obstructive lungrights reserved.
Fig. 1. Protocol of preoperative cardiac risk evaluation for patients scheduled for infrarenal aortic aneurysmectomy: in italics the
study project.
446 M. Bonazzi et al.disease, and mild chronic renal failure (serum creati-
nine level 53 mg/dl).
Acute Physiology And Chronic Health Evaluation
(APACHE II)13 was used to measure the severity of
illness present preoperatively in order to determine
whether control and treatment groups were similar;
Sequential Organ Failure Assessment (SOFA)14 score,
which takes into account 6 parameters of respiratory,
cardiovascular, hepatic, renal, neurological and coagu-
lation systems, was used to describe postoperative
individual organ dysfunction/failure in a continuous
form, from mild dysfunction (SOFA score  2) to dif-
ferent levels of failure (SOFA score  3 up to 24).
Criteria for exclusion were presence of advanced
chronic renal failure (serum creatinine level
 3.0 mg/dl or concomitant continuous or intermit-
tent replacement treatment), severe chronic obstruct-
ive lung disease which could anticipate the need for
postoperative ventilatory assistance, concomitant
aortoiliac obstructive disease.
This study protocol was approved by the Human
Ethics Committee of the hospital; informed written
consent was obtained from all patients.Eur J Vasc Surg Vol 23, May 2002Patients eligible were entered consecutively in the
order of their scheduled operations and they were
randomised in two groups: a computer-generated ran-
dom number was obtained by phone-call to the Statis-
tical Centre of the hospital on the day before surgery
and directed assignment to treatment or control
group.
1. Treatment group was admitted to ICU on the
morning of the day before surgery in order to institute
haemodynamic monitoring: radial artery of the non-
dominant hand was preferably cannulated and PAC
was inserted through the basilic vein under both
fluoroscopic and pressure monitoring. Preoperative
optimisation of cardiovascular status was defined by
the following goals, modified by Shoemaker et al.4
and Berlauk et al.:5 Cardiac Index (CI) 4 3.0 l/min/
sqm, Pulmonary Wedge Pressure (PWP) > 10
and 518 mmHg, Systemic Vascular Resistance
(SVR) 51450 dyne/sec/cmÿ5, Oxygen delivery
(DO2) > 600 ml/min/sqm.
When not `spontaneously' present, these therapeu-
tic goals were achieved by appropriate treatment:
volume-loading, consisting of 9 ml/kg normal saline
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additional fluid boluses when requested, until the
PWP was >10 and 518 mmHg, followed by intraven-
ous maintenance fluids at 1.5 ml/kg/hr; inotropic
drugs: dobutamine initiated in a dose of 2.5 mg/kg/
min and titrated upwards to CI4 3.0 l/min/sqm;
vasodilator drugs: nitroglycerin 10 mg/min titrated
upwards to SVR target.
Patient's discharge from ICU and transferring to the
surgical ward was scheduled at the end of the 2nd
postoperative day, if uneventful.
2. Control group remained in the surgical ward dur-
ing the perioperative period and no haemodynamic
monitoring other than central venous pressure
and invasive arterial pressure during surgery was
instituted.
In both groups, general anaesthesia was adminis-
tered following the same protocol: induction with
propofol 2 mg/kg and atracurium 0.1 mg/kg; IPPV
with nitrous oxide in oxygen at a FiO2 and with
a Tidal Volume to achieve SaO24 95% and
ETCO2 35 mmHg; maintenance with fentanyl in
continuous infusion at a rate of 5 mcg/kg/hour
atracurium when requested.
During postoperative period, in both groups ECG,
lactic dehydrogenase (LDH), creatine phosphokinase
(CK) and the MB isoenzyme (CKMB) and the serum
aminotransferase enzymes AST and ALT were con-
trolled every 6 hours after surgery for the first
48 hours and then daily monitored until the 6th post-
operative day and whenever clinically indicated, in
order to detect episodes of myocardial ischemia.
Whenever high postoperative values of total CK
were found, a qualitative troponin I test with a diag-
nostic cut-off value of 1.5 ng/ml (Spectral's CARDIAC
STATusTM Troponin I Rapid Test ± Princeton
BioMeditech Corp.) was also performed. Serum crea-
tinine concentration and blood urea nitrogen were
also monitored daily until the 6th postoperative day,
as biochemical markers of renal failure. Urine output
was measured hourly until the end of the 2nd post-
operative day, and every eight hours successively.
Duration of surgery, duration of aortic clamping,
intraoperative blood loss and replacement, amount
of crystalloid (`balanced' salt solutions e.g. normal
saline 0.9% or Ringer's lactate) administered peri-
operatively were registered in both groups.
The primary outcome variable analysed was:
 Cardiovascular morbidity: nonfatal myocardial
infarction, based on the existence of at least two of
the following criteria: (a) elevated CKMB isoenzyme
> 5% and positive simultaneous troponin I test,
(b) either new Q-waves or persistent new ST-Twave changes by 12-lead ECG (c) prolonged
(>30 minutes) typical chest pain; congestive heart
failure (CHF); arrhythmias requiring treatment
Others outcome variables considered were:
 In-hospital mortality
 Postoperative acute renal failure, defined as a
worsening of preoperative renal function with
accompanying oliguria requiring high doses of
furosemide (>250 mg/die) and or continuous or
intermittent replacement therapy
 Duration of postoperative hospital stay
Statistics: based on the review of the literature con-
cerning abdominal aneurysmectomy,15±17 we found
a 10% of major postoperative cardiac complications
(non-fatal myocardial infarction, congestive heart
failure, arrhythmias requiring treatment). In order to
verify the hypothesis that perioperative optimisation
of cardiovascular status can improve this endpoint,
we considered clinically important a reduction of
postoperative cardiovascular morbidity from 10% to
5%. To reveal such reduction, 446 patients in each
group would be required, based on the formula for
normal theory and assuming a two-sided type II error
protection of 0.05 and a power of 0.80. However, the
sample size could be even larger, if we consider that
perioperative cardiovascular morbidity and mortality
rates are probably lower in patients selected as CAD-
free. Since it is difficult to enrol such a large number of
patients in a single centre, we decided to conduct a
prospective, randomised pilot study with a limited
number of patients without clinical and echocardio-
graphic evidence of CAD.
Statistical analysis was performed using the appro-
priate software (SPSS for Windows version 6.1.3).
Pre-operative risk factors were compared using
Chi-square test with Yates correction with significance
level set at p5 0.05; outcomes and perioperative
management data were analysed by the chi-square
test with Yates correction for categorical data and
Mann±Whitney U test for continuous data, with
significance level set at p5 0.05.
Results
Hundred consecutive male patients satisfying the
entry criteria at the preoperative transthoracic echo-
cardiography were enrolled and randomly divided in
treatment and control groups.
Demographic data and medical history for each
group are shown in Table 1.Eur J Vasc Surg Vol 23, May 2002
Table 1. Demographic and medical data.
Treatment group
(N 50)
Control group
(N 50)
p
Mean age (range) 67 (63±75) 68 (62±75) N.S.
Smoke history (%) 27 (54) 32 (64) N.S.
C.O.L.D. (%) 18 (36) 15 (30) N.S.
Diabetes mellitus (%) 5 (10) 7 (14) N.S.
Hypertension (%) 16 (32) 15 (30) N.S.
Chronic renal
failure (%)
3 (6) 4 (8) N.S.
Mean APACHE II
preop. (range)
7 (6±10) 7 (5±10) N.S.
Table 2. Intraoperative data: results expressed as mean (range).
Treatment group
(N 50)
Control group
(N 50)
p
Operative time 175 (160±250) min 180 (160±245) min N.S.
Aortic clamping 75 (55±100) min 65 (50±90) min N.S.
Infusions 4500 (3250±6500) ml 3250 (2500±4750) ml 5 0.01
Blood loss 1000 (450±2750) ml 1100 (500±2500) ml N.S.
Cell saver 622 (400±1550) ml 580 (400±1400) ml N.S.
PRBC 825 (500±1500) ml 975 (500±2000) ml N.S.
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developed transient ventricular arrhythmias during
positioning of PAC, which did not require treatment.
At the preoperative haemodynamic evaluation, 35
patients (70%) met our haemodynamic endpoints
without any intervention, whilst 10 patients (20%) in
chronic diuretic therapy for hypertension needed vol-
ume loading alone and other 5 patient (10%) required
additional inotropic treatment with dobutamine at
low doses.
Intraoperative treatment (Table 2): in treatment group,
the total volume of infusions was significantly higher
than in control group (p5 0.01). At the declamping,
no episodes of arterial hypotension requiring pharma-
cological treatment were registered in treatment
group, whilst in control group 6 patients needed vol-
ume load and/or inotropic drugs (p5 0.05).
Postoperative treatment (Table 3): postoperative
severity scores did not differ significantly between
groups. In treatment group, 5 patient (10%) required
inotropic treatment with dobutamine at low doses.
Volume of infusions was significantly higher during
the 1st postoperative day; urine output remained sig-
nificantly higher than in control group during 1st and
2nd postoperative day.
In the treatment group at the end of the 2nd post-
operative day haemodynamic monitoring was with-
drawn in all cases and patients were discharged from
ICU and transferred to the vascular-surgical ward.
Postoperative outcome variables (Table 4): in both
groups in-hospital mortality, non-fatal myocardial in-
farction and postoperative renal failure rates were
null; no significant differences were noted in term of
duration of hospital stay between the groups.
Overall cardiac events occurred in 6 patients (6%),
two patients of treatment group and four patients in
control group; they included arrhythmias (two treat-
ment patients vs three control subjects) and CHF (no
treatment patient vs one control subject). In control
group there was one case of atrial fibrillation, treated
with electrical cardioversion, and two cases of
paroxysmal supraventricular tachycardia, requiringEur J Vasc Surg Vol 23, May 2002pharmacological treatment vs two cases of paroxys-
mal supraventricular tachycardia in treatment group.
In one of these two cases, the episode of paroxysmal
supraventricular tachycardia happened during with-
drawal of PAC and this was the only complication
related to the pulmonary artery catheterization
observed in treatment group.
Although control patients tended to have a slightly
higher incidence of individual cardiac events, differ-
ences between the groups did not achieve statistical
significance.
Discussion
In any clinical study, statistical significance can be
achieved with a relative small number of patients,
only if the tested group is at high risk for a bad
outcome; preselecting a subset of vascular patients at
lower risk for major adverse cardiac complications, as
our CAD-free population, any beneficial role of peri-
operative optimisation of haemodynamic profile is
more difficult to define in a relatively small sample,
and this was a limitation inherent in the pilot design of
our study. Therefore, even if our pilot prospective
randomised study could not demonstrate a benefit
from the perioperative haemodynamic optimisation
in terms of improvement of outcome variables
analysed, the risk of a type II statistical error must
be acknowledged. The prospective and randomised
design of our study, conducted on patients homo-
geneous in terms of preoperative cardiac risk strati-
fication, in a single vascular surgical centre,18
represents in any case a correct approach towards
a reliable documentation of postoperative cardiac
morbidity.
As a matter of fact, reported perioperative cardio-
vascular morbidity and mortality rates today are
lower in comparison with older studies,19 probably
because of better perioperative treatments. Sprung
et al.20 in their recent analysis of 6948 vascular surgical
elective and emergency vascular procedures, found a
2.06% incidence of myocardial infarction and a 0.44%
Table 3. Postoperative data: results expressed as mean (range).
Treatment group
(N 50)
Control group
(N 50)
p
SOFA 6 H. AFTER SURGERY 10 (6±12) 10 (6±12) N.S.
SOFA 1ST POSTOP. DAY 11 (6±13) 10 (6±12) N.S.
SOFA 2ND POSTOP. DAY 8 (6±10) 8 (6±10) N.S.
Infusions in 1st postop. day 3480 (3000±4750) ml 2900 (1900±3250) ml 5 0.01
Urine output in 1st postop. day 2360 (1825±2950) ml 1580 (975±1900) ml 5 0.01
Infusions in 2nd postop. day 3150 (2750±3600) ml 2980 (2250±3400) ml N.S.
Urine output in 2ndpostop. day 1523 (1100±2300) ml 1132 (850±2800) ml 5 0.01
Table 4. Results on outcome.
Treatment
Group
(N 50)
Control
Group
(N 50)
p
Mortality 0 0 N.S.
Non fatal m.i. 0 0 N.S.
Arrhythmias 2 3 N.S.
Congestive
Heart failure
0 1 N.S.
Renal failure 0 0 N.S.
Postoperative
Hospital stay
12 (range 9±17) 11 (range 8±15) N.S.
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If we consider that in the above mentioned study
patients with preoperative diagnosis of CAD were
60% in the group without cardiovascular postopera-
tive morbidity, and 85% in the group with post-
operative myocardial infarction, our results are not
surprising in their very low rate, since they are refer-
ring to patients selected as CAD-free.
In recent years the preoperative cardiac evaluation
of the patient with vascular disease in order to detect
the presence and degree of CAD has gained increased
importance for many reasons.21
First of all, coronary angiography performed before
surgery has shown that significant CAD exists in
approximately 60% of patients scheduled for major
vascular surgery, although asymptomatic and that
only 8% are completely CAD-free.22,23 Moreover, pre-
operative coronary interventions in symptomatic
cases may be indicated to improve long-term survival
in patients scheduled for major aortic surgery.24
Therefore, preoperative cardiac stratification to assess
operative risk seems to be the major effort, and several
non-invasive techniques have been suggested to
improve the preoperative risk stratification in vascular
surgical patients.25,26
The protocol used in our institution is based as first
step on transthoracic echocardiography, to detect left
ventricular wall motion abnormalities as a significant
marker of CAD27 in formerly asymptomatic patientswithout significant alterations of repolarization at
resting electrocardiogram; ECG treadmill testing has
not been chosen as preoperative screening method
because most of the vascular patients are not able
to perform an adequate physical exercise. For this
reason, patients with not significant coronary artery
stenosis or with a critical stenosis although less than
85% ± which means a reduced coronary artery flow at
rest ± may have been ignored by our protocol, adopt-
ing transthoracic echocardiography.
We cannot exclude that any of these patients could
have manifested episodes of myocardial ischemia dur-
ing intra or postoperative period, which have not been
detected by our monitoring protocol. In fact, the diag-
nosis of postoperative myocardial infarction based on
CK-MB isoenzymes in patients undergoing aortic
surgery is prone to error;28 the use of qualitative
troponin I test in cases with high postoperative values
of total CK, although not as effective as quantitative
one, should have improved the diagnostic accuracy
of our protocol. In any case, even if these episodes
happened, their clinical relevance has been very low
and they did not affect the outcome, probably due to
their eventually limited severity. At any rate, because
there was an equal risk of missed complications in
both groups, it is doubtful that the results would
have been altered significantly.
Only one PAC-related complication occurred in
treatment group (episode of paroxysmal supraventri-
cular tachycardia during withdrawal of PAC); this low
incidence of complications is due to the deliberate
choice to avoiding central venous route to minimise
the risk of puncture-related complications and to
performing pulmonary artery catheterization under
both fluoroscopic and pressure monitoring, in order
to prevent incorrect placement and the need of further
repositioning.
Recently, some prospective trials suggested that the
use of PAC for perioperative monitoring could be det-
rimental in terms of increase of cardiac and pulmonary
complications8 and of length of ICU and hospital
stay;30 our data do not support these observations.Eur J Vasc Surg Vol 23, May 2002
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namic profile on the above mentioned `goal directed'
basis, to maintain the left ventricular filling pressure
and the cardiac index at the established values, is the
reason why no episodes of arterial hypotension at
the declamping requiring pharmacological treatment
were registered, whilst in control group 6 patients
needed volume loading and/or inotropic drugs
(p5 0.05). For the same reason, a statistically signifi-
cant higher volume of crystalloids was infused during
the first postoperative day and a higher urine output
resulted postoperatively. This is a common observa-
tion to all the studies that employed PAC in the peri-
operative management of vascular patients8,9 and
probably reflects more confidence to push fluids in,
without the fear of causing complications, because of
the margin of safety given by knowing the actual PWP.
Recently, some studies have been performed in
order to identify cost savings strategies, particularly
in terms of bed utilisation and length of hospital
stay, for patients scheduled for major vascular sur-
gery, with results that are often contradictory and
confusing.
D'Angelo et al.30 in their retrospective study on 113
patients submitted to infrarenal aneurysm repair com-
pared 74 patients with only a preoperative electrocar-
diogram and 39 patients with additional testing that
included thallium stress test or echocardiogram or
cardiac catheterization and concluded that preopera-
tive cardiac testing does not affect postoperative mor-
tality and morbidity and is therefore not usually
necessary, whilst perioperative haemodynamic man-
agement, with therapeutic end-points similar to those
adopted in our treatment group, may be the most
important variable in determining outcome.
Opposite conclusions have been drawn by Fleisher
et al.31 who recently reviewed data of Medicare
beneficiaries to determine the mortality rate after vas-
cular surgery and noted a reduced perioperative and
long-term mortality in patients who had previously
undergone preoperative cardiac assessment, in com-
parison with those not submitted to preoperative
cardiac testing.
We think that an accurate preoperative cardiac-risk
stratification plays a pivotal role in outlining the
perioperative management strategies; in patients
selected through our preoperative cardiac evaluation
protocol as CAD-free however, the postoperative mor-
tality and cardiovascular morbidity is too low, in our
opinion, to justify a controlled randomised study,
which would require a considerable effort in selecting
and enrolling a quite large number of patients.
The pilot design of our study does not allow
any conclusions, but we reasonably speculate that inEur J Vasc Surg Vol 23, May 2002CAD-free selected patients haemodynamic optimisa-
tion is not beneficial. Its role in preventing periopera-
tive cardiovascular mortality and morbidity in
different subsets of patients with more severe cardiac
impairment at preoperative evaluation must be
addressed with further controlled studies.
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